Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Clinical trial NCT00343733 · COMPLETED
Trial details
- NCT number
- NCT00343733
- Sponsor
- Cephalon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.